ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $66 | -99.9% | 3,087 | -47.4% | 0.00% | – |
| Q3 2022 | $113,000 | 0.0% | 5,865 | +3.0% | 0.00% | – |
| Q2 2022 | $113,000 | +334.6% | 5,694 | +406.1% | 0.00% | – |
| Q4 2021 | $26,000 | -10.3% | 1,125 | +34.7% | 0.00% | – |
| Q3 2021 | $29,000 | 0.0% | 835 | 0.0% | 0.00% | – |
| Q2 2021 | $29,000 | -74.3% | 835 | -74.2% | 0.00% | – |
| Q1 2021 | $113,000 | +438.1% | 3,234 | +477.5% | 0.00% | – |
| Q4 2020 | $21,000 | -97.7% | 560 | -98.0% | 0.00% | -100.0% |
| Q3 2020 | $919,000 | +371.3% | 27,543 | +274.1% | 0.00% | – |
| Q2 2020 | $195,000 | +126.7% | 7,363 | +39.8% | 0.00% | – |
| Q1 2020 | $86,000 | +1620.0% | 5,265 | +2150.0% | 0.00% | – |
| Q4 2019 | $5,000 | -90.7% | 234 | -91.4% | 0.00% | – |
| Q3 2019 | $54,000 | +285.7% | 2,716 | +521.5% | 0.00% | – |
| Q1 2019 | $14,000 | 0.0% | 437 | -26.1% | 0.00% | – |
| Q4 2018 | $14,000 | – | 591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |